Clinical Haematology strongly on display at the 2025 American Society of Hematology Meeting
12 December 2025
Researchers from the Peter Mac and Royal Melbourne Hospital combined clinical haematology service have showcased their research leadership at the American Society of Hematology (ASH) Meeting, the world’s most respected haematology forum.
The clinical haematology team contributed to 24 oral abstracts, led one education session, presented research in 51 posters, and featured in plenary sessions. Outstandingly, the team led research projects featured in two of the six highly prestigious late-breaking abstracts presented.
Professor David Ritchie, Interim Medical Director, Haematology at Peter Mac, said the breadth of contributions reflected the strength, innovation, and international reach of our program.
“Our teams presented research that will influence practice worldwide from innovative genomics and diagnostic approaches to advances in immunotherapy and targeted therapies,” he said.
“The whole haematology team is also proud to celebrate Professor Mark Dawson’s achievement of being honoured with the William Dameshek Prize, one of ASH’s most significant prizes.
“I am incredibly proud of our researchers and clinicians. Their visibility at ASH this year shows the international impact of our service on the future of haematology.”
Some of the key presentations from Peter Mac staff included:
- Dr Lucy Fox showcased late-breaking findings from the IBMDx study, highlighting the power of whole genome and transcriptome sequencing for patients with suspected inherited bone marrow failure syndromes.
- Professor Simon Harrison also contributed to a second late-breaking abstract focused on a first-in-human trial for relapsed or refractory multiple myeloma.
- Dr Mark Dowling presented departmental research on a simple scoring system for response and toxicity following lymphoma CAR-T: results from the Australian CAR-T Real-World Consortium.
- Associate Professors Philip Thompson, and Lynette Chee presented their research in oral sessions.
- Associate Professor Piers Blombery, a leader in genomics, led a scientific workshop on translational diagnostics in minimal residual disease - next generation sequencing, ctDNA and beyond.
- Professor Paul Neeson presented the correlative immunology research of the coalition study run by haematologists Professor Michael Dickinson and Dr Adrian Minson.
Clinical haematology’s strong presence at ASH 2025 continues to underscore the service’s international leadership in advancing haematology research and delivering innovations that will benefit patients in Australia and worldwide.